DraxImage Sestamibi (2016-10-14)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 5H021A | - Recalling Firm
- Jubilant Draximage Inc
- 16751 Trans-Canada Highway
- Kirkland
- H9H 4J4
- Quebec
- CANADA
- Marketing Authorization Holder
- Jubilant HollisterStier Contract Manufacturing & Services
- 16751 Trans Canada Highway
- Kirkland
- H9H 4J4
- Quebec
- CANADA
| DraxImage Sestamibi | Powder for solution | Not Applicable | 1 mg / vial of Tetrakis [CU(MIB)4BF4] |
Out of specification result for the oxygen content during stability testing.